About: Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 1995

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 1995 (uk) article scientifique publié en 1995 (fr) im Juli 1995 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 1995 (ast) scientific article published on 01 July 1995 (en)
publication date	wds:Q71857088-03664FC6-F53E-439A-8F59-4AAC01892565
publication date	1995-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71857088-7EE6D090-0F8A-4E4D-8CB5-4E7D2A04C4CB
language of work or name	English
cites work	wds:Q71857088-295EB530-C49D-4C6D-BE2C-1F6067567229 wds:Q71857088-80ED80DB-713F-40A6-BBD4-51C8D5AB79A1 wds:Q71857088-812AED8B-9CD6-4786-9119-D60D3954691E wds:Q71857088-87517CB2-A564-4B7D-931F-E75C889232B3
cites work	Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia Long-term treatment of hypercholesterolemia with fluvastatin: a 52-week multicenter safety and efficacy study. French-Dutch Fluvastatin Study Group.
author name string	wds:Q71857088-7843DB5B-9039-4AA9-964E-19DF3AE8854F wds:Q71857088-8990205D-859C-4200-B0B8-CB25211BC1C6 wds:Q71857088-9406067A-B6E6-42E0-8331-E1035882E507 wds:Q71857088-9B4DD1AF-77B1-4636-8DDB-ADF3CDB36924
author name string	J W Smit T W de Bruin D W Erkelens G H Jansen
rdfs:label	Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage (en) Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage (nl)
skos:prefLabel	Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage (en) Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage (nl)
name	Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage (en) Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage (nl)
title	wds:Q71857088-8111370D-4701-4630-A687-377D08A32DDA
title	Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage (en)
page(s)	wds:Q71857088-11237DD0-204B-473A-AE93-6426A2BF86E9
page(s)	126A-128A
instance of	wds:Q71857088-06344ECF-B1E4-4960-B27D-91453655CD0A
instance of	scholarly article
main subject	wds:Q71857088-47F1E213-0DFF-4B44-821A-3C15CFC3207C
main subject	mixed hyperlipidemia
PubMed ID	wds:Q71857088-64955AB3-ABDA-4D61-92E8-D25B14E3F4E6
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7604787
PubMed ID	7604787
published in	wds:Q71857088-DA6E5BBD-F44E-4FD4-A4AF-5C8A27007CA4
published in	American Journal of Cardiology
issue	wds:Q71857088-AF72C0A2-596B-40BD-AB31-C32A4E6A3020
volume	wds:Q71857088-3F503912-9D88-4D95-8666-F99CB1475BE5
issue	2
volume	76
DOI	wds:Q71857088-0F4177EF-6380-43B5-8049-81DC2CF75746
DOI	http://dx.doi.org/10.1016/S0002-9149(05)80034-7
DOI	10.1016/S0002-9149(05)80034-7
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71857088
is cites work of	Pharmacokinetics of the combination of fluvastatin and gemfibrozil Efficacy and safety of a combination of fluvastatin and bezafibrate in patients with mixed hyperlipidaemia (FACT study) Role of fibrates in the management of hypertriglyceridemia Effect of combined fluvastatin-fenofibrate therapy compared with fenofibrate monotherapy in severe primary hypercholesterolemia. French Fluvastatin Study Group Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidaemia Clinical positioning of HMG-CoA reductase inhibitors in lipid management protocols Effect of Fluvastatin on Lipids and Fibrinolysis in Coronary Artery Disease Frequency of creatine kinase elevation during treatment with fluvastatin in combination with fibrates (bezafibrate, fenofibrate, or gemfibrozil). Long-term safety and efficacy of combination gemfibrozil and HMG-CoA reductase inhibitors for the treatment of mixed lipid disorders Effects of baseline level of triglycerides on changes in lipid levels from combined fluvastatin + fibrate (bezafibrate, fenofibrate, or gemfibrozil). Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors Myopathy with statin-fibrate combination therapy: clinical considerations Statin therapy for the treatment of diabetic dyslipidemia Combination lipid-altering therapy: an emerging treatment paradigm for the 21st century Fluvastatin for lowering lipids Drug administration in patients with diabetes mellitus. Safety considerations Pharmacological interactions of statins
is cites work of	wds:Q44274311-D72FA5FA-1EE2-439F-8F86-A8254C65D687 wds:Q44601020-4FD84229-69E8-4269-8EB9-EC868282257F wds:Q58823398-A2A3C0EE-DD38-4A09-88BB-232014E31931 wds:Q73901933-7D6A54C7-9F18-4C9B-9A22-35DE0EC09FBA wds:Q77933878-69D773D4-939F-4C72-B4C7-324965F927F9 wds:Q33646070-85E9199A-2ED5-47D0-B067-300C77AE7FF8 wds:Q33652033-7DCB72CF-58C0-4144-ACDC-22AB17C9FA9D wds:Q37563958-AAC54FC2-0752-4B0F-8272-FBF098AAA839 wds:Q41060497-A8DAEDB7-F758-432D-9001-0BDEB1BCED23 wds:Q74692842-FFE30572-CC56-4413-BAD6-A4723A300FED wds:Q33742346-346B5499-A668-4556-8692-19634228F393 wds:Q42678980-49A844F4-4148-41C3-9AC5-958B7736DD42 wds:Q35184296-06FAC1FF-6231-4E88-966E-841DD1F14CE9 wds:Q44394058-998114E1-84C1-4317-BE41-F600D21A07DC wds:Q56386465-77027F77-AA13-4E6D-9296-3D228AB4B66F wds:Q34327226-CB4FD955-7B73-41D9-874A-22D9C05F4DEF wds:Q73189647-EE04B9B9-1436-4A7C-A6D8-1C318BB241B1

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software